🔴 Indaptus Therapeutics is trading 6.5% down today as biotech ETF XBI falls

Indaptus Therapeutics is trading 6.5% down now at $3.40, with the decline appearing primarily sector-driven.

• Biotech ETF XBI was down 2.11% during regular trading.
• Shares rallied from $1.22 on September 4 to $3.64 on September 15 across five sessions.
• Investors may also be consolidating gains after the company’s recently announced approximately $24 million private placement of 20,338,974 shares, intended for working capital and research programs.